Aspirin should not be used, or used carefully, in patients with clinically significant acquired von Willebrand syndrome or a very-low-risk score (Age ≤60, no JAK2 mutation, and no history of thrombosis) [16]. This evidence concerns the gene JAK2 and deep vein thrombosis.